Diagnosis and management of retinoblastoma

Cancer Control

Volumn 11, Issue 5, 2004, Pages 317-327

  Shields, Carol L ^a,b   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; VINCRISTINE;

ADVANCED CANCER; BEAM THERAPY; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CELL LOSS; CHROMOSOME 13Q; CHROMOSOME DELETION 13; CLINICAL FEATURE; CONJUNCTIVA DISEASE; CONJUNCTIVAL HEMORRHAGE; CRYOTHERAPY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DRUG PENETRATION; ENUCLEATION; EYE MOVEMENT DISORDER; EYE PAIN; FIBROSIS; HUMAN; HYPERTHERMIC THERAPY; INFECTION; LASER COAGULATION; LENS DISEASE; LEUKEMIA; MEDICAL CARE; METASTASIS; NEPHROTOXICITY; NONHUMAN; OPTIC NERVE LESION; ORBIT DISEASE; OTOTOXICITY; RETINA INJURY; RETINOBLASTOMA; RETINOPATHY; REVIEW; SIDE EFFECT; TREATMENT FAILURE; UNITED STATES;

EID: 14644397851     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480401100506     Document Type: Review

References (65)

1. Shields JA, Shields CL. Management and prognosis of retinoblastoma. In: Intraocular Tumors: A Text and Atlas. Philadelphia, Pa; WB Saunders; 1992.
2. Shields JA, Shields CL. Retinoblastoma. In: Shields JA, Shields CL, eds. Atlas of Intraocular Tumors, Philadelphia, Pa: Lippincott Williams & Wilkins; 1999.
3. Devesa SS. The incidence of retinoblastoma. Am J Ophthalmol. 1975;80:263-265.
4. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-646.
5. Donoso LA, Shields CL, Lee EY. Immunohistochemistry of retinoblastoma: a review. Ophthalmic Paediatr Genet. 1989;10:3-32.
6. Shields CL, Shields JA. Genetics of retinoblastoma. In: Tasman WS, Jaeger E, eds. Duane's Foundations of Clinical Ophthalmology. 3rd ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2002.
7. Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus. 1999;36:8-18.
8. Shields JA, Shields CL. Genetics of retinoblastoma. In: Shields JA, Shields CL, eds. Intraocular Tumors: A Text and Atlas. Philadelphia, Pa: WB Saunders; 1992:333-340.
9. Desai VN, Shields CL, Shields JA, et al. Retinoblastoma associated with holoprosencephaly. Am J Ophthalmol. 1990;109:355-356.
10. Knudson AG Jr, Meadows AT, Nichols WW, et al. Chromosomal deletion and retinoblastoma. N Engl J Med. 1976;295:1120-1123.
11. Allderdice PW, Davis JG, Miller OJ, et al. The 13q- deletion syndrome. Am J Hum Genet. 1909;21:499-512.
12. Seidman DJ, Shields JA, Augsburger JJ, et al. Early diagnosis of retinoblastoma based on dysmorphic features and karyotype analysis. Ophthalmology. 1987;94:663-666.
13. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120:923-931.
14. Shields CL, Shields JA, Baez K, et al. Optic nerve invasion of retinoblastoma: metastatic potential and clinical risk factors. Cancer. 1994;73:692-698.
15. Shields CL, Shields JA, Baez KA, et al. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77:544-548.
16. Donoso LA, Rorke LB, Shields JA, et al. S-antigen immunoreactivity in trilateral retinoblastoma. Am J Ophthalmol. 1987;103:57-62.
17. Pesin SR, Shields JA. Seven cases of trilateral retinoblastoma. Am J Ophthalmol. 1989;107:121-126.
18. De Potter P, Shields CL, Shields JA. Clinical variations of trilateral retinoblastoma: a report of 13 cases. J Pediatr Ophthalmol Strabismus. 1994;31:26-31.
19. Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol. 1999;17:1829-1837.
20. Bader JL, Miller RW, Meadows AT, et al. Trilateral retinoblastoma. Lancet. 1980;2:582-583.
21. Shields CL, Meadows AT, Shields JA, et al. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol. 2001;119:1269-1272.
22. Abramson DH, Ronner HJ, Ellsworth RM. Second tumors in nonirradiated bilateral retinoblastoma. Am J Ophthalmol. 1979;87:624-627.
23. Abramson DH, Melson MR, Dunkel IJ, et al. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology. 2001;108:1868-1876.
24. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol. 1963;67:164-172.
25. Shields CL, Mashayekhi A, Demirci H, et al. Practical approach to management of retinoblastoma. Arch Ophthalmol. 2004;122:729-735.
26. Shields JA, Parsons HM, Shields CL, et al. Lesions simulating retinoblastoma. J Pediatr Ophthalmol Strabismus. 1991;28:338-340.
27. Shields CL, Mashayekhi A, Luo CK, et al. Optical coherence tomography in children: analysis of 44 eyes with intraocular tumors and simulating conditions. In press.
28. Shields CL, Meadows AT, Leahey AM, et al. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina. 2004. In press.
29. Shields CL, Shields JA. Editorial: chemotherapy for retinoblastoma. Med Pediatr Oncol. 2002;38:377-378.
30. Ferris FL 3rd, Chew EY. A new era for the treatment of retinoblastoma. Arch Ophthalmol. 1996;114:1412.
31. Kingston JE, Hungerford JL, Madreperla SA, et al. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1339-1343.
32. Gallic BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol. 1996;114:1321-1328. Erratum in: Arch Ophthalmol. 1997;115:525.
33. Murphree AL, Villabianca JG, Deegan WF III, et al. Chemotherapy-plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348-1356.
34. Shields CL, De Potter P, Himelstein BP, et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1330-1338.
35. Shields CL, Shields JA, De Potter P, et al. The effect of chemoreduction on retinoblastoma-induced retinal detachment. J Pediatr Ophthalmol Strabismus. 1997;34:165-169.
36. Ellsworth RM. Retinoblastoma. Mod Prob Ophthalmol. 1977;96:1826-1830.
37. Hungerford JL, Toma NM, Plowman PN, et al. External beam radiotherapy for retinoblastoma: I. Whole eye technique. Br J Ophthalmol. 1995;79:109-111.
38. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol. 2002;133:657-664.
39. Wilson MW, Rodriguez-Galindo CR, Haik BG, et al. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Ophthalmology. 2001;108:2106-2115.
40. Shields CL, Honavar SG, Shields JA, et al. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol. 2002;120:460-464.
41. Shields CL, Shelil A, Cater J, et al. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Arch Ophthalmol. 2003;121:1571-1576.
42. Shields CL, Mashayekhi A, Cater J, et al. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004. In press.
43. Gombos DS, Kelly A, Coen PG, et al. Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location and age. Br J Ophthalmol. 2002;86:80-83.
44. Shields CL, Mashayekhi A, Shelil A, et al. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. In press.
45. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18:12-17.
46. Harbour JW, Murray TG, Hamasaki D, et al. Local carboplatin therapy in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci. 1996;37:1892-1898.
47. Murray TG, Cicciarelli N, O'Brien JM, et al. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma. Arch Ophthalmol. 1997;115:1286-1290.
48. Mendelsohn ME, Abramson DH, Madden T, et al. Intraocular concentrations of chemotherapeutic agents after systemic or local administration. Arch Ophthalmol. 1998;116:1209-1212.
49. Abramson DH, Frank CM, Dunkel IJ. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology. 1999;106:1947-1950.
50. Mulvihill A, Budning A, Jay V, et al. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol. 2003;121:1120-1124.
51. Shields CL, Shields JA, Kiratli H, et al. Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation. J Pediatr Ophthalmol Strabismus. 1995;32:317-322.
52. Shields CL, Santos MC, Diniz W, et al. Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999;117:885-893.
53. Shields JA, Parsons H, Shields CL, et al. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol. 1989;108;260-264.
54. Shields CL, Shields JA, De Potter P, et al. Plaque radiotherapy in the management of retinoblastoma: use as a primary and secondary treatment. Ophthalmology. 1993;100:216-224.
55. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for retinoblastoma: long term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001;108:2116-2121.
56. Toma NM, Hungerford JL, Plowman PN, et al. External beam radiotherapy for retinoblastoma: II. Lens sparing technique. Br J Ophthalmol. 1995;79:112-117.
57. Weiss AH, Karr DJ, Kalina RE, et al. Visual outcomes of macular retinoblastoma after external beam radiation therapy. Ophthalmology. 1994;101:1244-1249.
58. Wong FL, Boice JD Jr, Abramson DH, et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA. 1997;278:1262-1267.
59. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with retinoblastoma. Ophthalmology. 1988;95:1583-1587.
60. Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. Int J Cancer. 1996;67:515-519.
61. Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology. 1998;105:573-579.
62. Shields JA, Shields CL, Sivalingam V. Decreasing frequency of enucleation in patients with retinoblastoma. Am J Ophthalmol. 1989;108:185-188.
63. Epstein JA, Shields CL, Shields JA. Trends in the management of retinoblastoma: evaluation of 1,196 consecutive eyes during 1974-2001. J Pediatr Ophthalmol Strabismus. 2003;40:196-203.
64. Shields CL, Shields JA, De Potter P, et al. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc. 1993;91:177-189.
65. Shields JA, Shields CL, De Potter P. Enucleation technique for children with retinoblastoma. J Pediatr Ophthalmol Strabismus. 1992;29:213-215.